Rani Therapeutics Holdings, Inc. (RANI) Tops Q1 EPS by 15c

Rani Therapeutics Holdings, Inc. (NASDAQ: RANI) reported Q1 EPS of ($0.33), $0.15 better than the analyst estimate of ($0.48).

For earnings history and earnings-related data on Rani Therapeutics Holdings, Inc. (RANI) click here.

You May Also Be Interested In

• Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
• Bernstein SocGen Group Upgrades X-Fab Silicon Foundries SE (XFAB:FP) to Outperform
• AeroVironment restates quarterly financials, citing $89M goodwill error